Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (1): 61-64    DOI: 10.12891/ceog3254.2017
Original Research Previous articles | Next articles
Follow-up study of symptomatic submucous fibroids after hysteroscopic myomectomy
H. Tsujioka1, *(), S. Matsuoka1, S. Sorano1, H. Yamamoto1, S. Nakamura1, A. Tohyama1, T. Fukami1, M. Goto1, R. Matsuoka1, F. Eguchi1
1 Department of Obstetrics and Gynecology, Iizuka Hospital, Iizuka, Japan
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of investigation: This study aimed to estimate the effectiveness of hysteroscopic myomectomy for symptomatic submucous uterine fibroids and to identify prognostic factors for persistent or recurrent symptoms. Materials and Methods: A total of 237 patients who underwent hysteroscopic myomectomy were divided into three groups according to the classification of the European Society for Gynaecological Endoscopy: Type 0 (n=116), Type I (n=97), and Type II (n=24). Medical records and videotape records of all patients were retrospectively reviewed. Results: Improvement of symptoms was achieved in 100% of Types 0 and I, and 66.7% of Type II. The five-year cumulative symptom-free rates after hysteroscopic myomectomy were 96.7% ± 1.9%, 87.8% ± 6.7%, and 44.5% ± 12.7% in Types 0, I, and II, respectively. The mean symptom-free periods were 46.2 ± 2.6, 47.7 ± 2.7, and 24.7 ± 6.3 months in Types 0, I, and II, respectively. Logistic regression analysis showed that co-existence of other myomas and Type II were independent prognostic factors for recurrence of symptoms. Conclusion: Type I fibroids are a good indication for hysteroscopic myomectomy. In Type II, some patients feel that their symptoms improve, but this curative effect could be temporary.
Key words:  Hysteroscopic myomectomy      Symptomatic submucous fibroid     
Published:  10 February 2017     
*Corresponding Author(s):  H. TSUJIOKA     E-mail:  htsujiokah1@aih-net.com

Cite this article: 

H. Tsujioka, S. Matsuoka, S. Sorano, H. Yamamoto, S. Nakamura, A. Tohyama, T. Fukami, M. Goto, R. Matsuoka, F. Eguchi. Follow-up study of symptomatic submucous fibroids after hysteroscopic myomectomy. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 61-64.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3254.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I1/61

[1] V. Fiaschetti, M. Fornari, V. Cama, M. Rascioni, V. Liberto, G. Sorrenti, G. Simonetti. MRI in the assessment of prolapsed pedunculated submucous leiomyomas: two case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(6): 827-832.
[2] P. Litta, C. Leggieri, L. Conte, A. Dalla Toffola, F. Multinu, S. Angioni. Monopolar versus bipolar device: safety, feasibility, limits and perioperative complications in performing hysteroscopic myomectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(3): 335-338.
[3] I. Stamatellos, G. Koutsougeras, D. Karamanidis P. Stamatopoulos, I. Timpanidis, J. Bontis. Results after hysteroscopic management of premenopausal patients with dysfunctional uterine bleeding or intrauterine lesions[J]. Clinical and Experimental Obstetrics & Gynecology, 2007, 34(1): 35-38.
[4] R. Marziani, B. Mossa, V. Ebano, G. Perniola, J. Melluso, C. Napolitano. Transcervical hysteroscopic myomectomy: long-term effects on abnormal uterine bleeding[J]. Clinical and Experimental Obstetrics & Gynecology, 2005, 32(1): 23-26.
No Suggested Reading articles found!